<?xml version="1.0" encoding="UTF-8"?>
<urlset xmlns="http://www.sitemaps.org/schemas/sitemap/0.9" xmlns:image="http://www.google.com/schemas/sitemap-image/1.1" xmlns:xhtml="http://www.w3.org/1999/xhtml" xmlns:video="http://www.google.com/schemas/sitemap-video/1.1">
  <url>
    <loc>https://www.alawtx.com/news1</loc>
    <changefreq>daily</changefreq>
    <priority>0.75</priority>
    <lastmod>2026-05-29</lastmod>
  </url>
  <url>
    <loc>https://www.alawtx.com/news1/alaw-therapeutics-announces-two-major-pipeline-milestones-advancing-brain-penetrant-cdk-oncology-programs</loc>
    <changefreq>monthly</changefreq>
    <priority>0.5</priority>
    <lastmod>2026-05-29</lastmod>
    <image:image>
      <image:loc>https://images.squarespace-cdn.com/content/v1/6a109d01192d89623b1d718f/1780091535002-96LSIENVLY0YCTBEDHZS/Alaw+therapeutics++PR+release+image.png</image:loc>
      <image:title>News - Alaw Therapeutics Announces Two Major Pipeline Milestones Advancing Brain-Penetrant CDK Oncology Programs - Phase 1a/b Study for Selective Brain-Penetrant CDK2 Inhibitor AL-605 doses patients; Selective Brain-Penetrant CDK4 Inhibitor AL-433 on Track for First-in-Human Study</image:title>
    </image:image>
  </url>
  <url>
    <loc>https://www.alawtx.com/news1/category/press+releases</loc>
    <changefreq>monthly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://www.alawtx.com/publications-1</loc>
    <changefreq>daily</changefreq>
    <priority>0.75</priority>
    <lastmod>2026-05-22</lastmod>
  </url>
  <url>
    <loc>https://www.alawtx.com/publications-1/ze74-0282-is-a-novel-jak2-jh2-domain-inhibitor-with-promising-preclinical-activity-in-jak2v617f-mutant-diseases-mt77l</loc>
    <changefreq>monthly</changefreq>
    <priority>0.5</priority>
    <lastmod>2026-01-09</lastmod>
    <image:image>
      <image:loc>https://images.squarespace-cdn.com/content/v1/6a109d01192d89623b1d718f/1779473714167-EVMNRXRVP2ZI9SR43OIV/ZE74-0282+is+a+novel+JAK2+JH2+domain+inhibitor+with+promising+preclinical+activity+in+JAK2V617F+mutant+diseases</image:loc>
      <image:title>Publications - ZE74-0282 is a novel JAK2 JH2 domain inhibitor with promising preclinical activity in JAK2V617F mutant diseases - Make it stand out</image:title>
      <image:caption>Whatever it is, the way you tell your story online can make all the difference.</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://www.alawtx.com/publications-1/discovery-of-a-novel-selective-brain-penetrant-cdk2-inhibitor-for-targeted-cancer-therapy-7l389</loc>
    <changefreq>monthly</changefreq>
    <priority>0.5</priority>
    <lastmod>2026-01-09</lastmod>
    <image:image>
      <image:loc>https://images.squarespace-cdn.com/content/v1/6a109d01192d89623b1d718f/1779473714123-X53UB20G68RCTNR2PVLK/Poster+CDK2+AACR_NCI_EORTC_Boston_102425.png</image:loc>
      <image:title>Publications - Discovery of a novel, selective brain penetrant CDK2 inhibitor for targeted cancer therapy - Make it stand out</image:title>
      <image:caption>Whatever it is, the way you tell your story online can make all the difference.</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://www.alawtx.com/about</loc>
    <changefreq>daily</changefreq>
    <priority>0.75</priority>
    <lastmod>2026-05-26</lastmod>
    <image:image>
      <image:loc>https://images.squarespace-cdn.com/content/v1/6a109d01192d89623b1d718f/1779473666647-DLCCHK77XO1Y5L686EKH/2+%287%29.png</image:loc>
    </image:image>
  </url>
  <url>
    <loc>https://www.alawtx.com/approach</loc>
    <changefreq>daily</changefreq>
    <priority>0.75</priority>
    <lastmod>2026-05-26</lastmod>
    <image:image>
      <image:loc>https://images.squarespace-cdn.com/content/v1/6a109d01192d89623b1d718f/1779473668630-NQAY9CCQFGEW7OCVCZ99/3+%287%29.png</image:loc>
    </image:image>
  </url>
  <url>
    <loc>https://www.alawtx.com/home</loc>
    <changefreq>daily</changefreq>
    <priority>1.0</priority>
    <lastmod>2026-05-29</lastmod>
    <image:image>
      <image:loc>https://images.squarespace-cdn.com/content/v1/6a109d01192d89623b1d718f/881909dc-4939-4c5f-845b-e543392be221/OrbiMed.svg.png</image:loc>
    </image:image>
    <image:image>
      <image:loc>https://images.squarespace-cdn.com/content/v1/6a109d01192d89623b1d718f/b5bc48b6-40fd-4ac9-b167-ee976cec2c7a/TorreyPinesInv+logo+no+background.png</image:loc>
    </image:image>
  </url>
  <url>
    <loc>https://www.alawtx.com/sab</loc>
    <changefreq>daily</changefreq>
    <priority>0.75</priority>
    <lastmod>2026-05-27</lastmod>
    <image:image>
      <image:loc>https://images.squarespace-cdn.com/content/v1/6a109d01192d89623b1d718f/1779473696301-VT9DQSEVR9BWT1XLKZT6/8+%283%29.png</image:loc>
      <image:title>Scientific Advisory Board</image:title>
    </image:image>
    <image:image>
      <image:loc>https://images.squarespace-cdn.com/content/v1/6a109d01192d89623b1d718f/0a83875e-1c87-4ba7-83e8-c7350ba30bee/Ruben+Abagyan.png</image:loc>
      <image:title>Scientific Advisory Board</image:title>
    </image:image>
  </url>
  <url>
    <loc>https://www.alawtx.com/contact</loc>
    <changefreq>daily</changefreq>
    <priority>0.75</priority>
    <lastmod>2026-05-29</lastmod>
  </url>
  <url>
    <loc>https://www.alawtx.com/pipeline</loc>
    <changefreq>daily</changefreq>
    <priority>0.75</priority>
    <lastmod>2026-05-27</lastmod>
  </url>
  <url>
    <loc>https://www.alawtx.com/board-of-directors</loc>
    <changefreq>daily</changefreq>
    <priority>0.75</priority>
    <lastmod>2026-05-26</lastmod>
    <image:image>
      <image:loc>https://images.squarespace-cdn.com/content/v1/6a109d01192d89623b1d718f/1779473716116-ZHURGN7SFB50JUNJE9YF/Untitled+design+%286%29.png</image:loc>
      <image:title>Board of Directors</image:title>
    </image:image>
    <image:image>
      <image:loc>https://images.squarespace-cdn.com/content/v1/6a109d01192d89623b1d718f/1779473716128-1MKT64Q1WNWR535R9OW1/3.png</image:loc>
      <image:title>Board of Directors</image:title>
    </image:image>
    <image:image>
      <image:loc>https://images.squarespace-cdn.com/content/v1/6a109d01192d89623b1d718f/1779473716137-597NAEU9IXDQ8YJMOOV7/Untitled+design+%2880%29.png</image:loc>
      <image:title>Board of Directors</image:title>
    </image:image>
    <image:image>
      <image:loc>https://images.squarespace-cdn.com/content/v1/6a109d01192d89623b1d718f/1779473716146-1XZTA25PJ112GWWJH5VI/10+%283%29.png</image:loc>
      <image:title>Board of Directors</image:title>
    </image:image>
  </url>
  <url>
    <loc>https://www.alawtx.com/management-team</loc>
    <changefreq>daily</changefreq>
    <priority>0.75</priority>
    <lastmod>2026-06-08</lastmod>
    <image:image>
      <image:loc>https://images.squarespace-cdn.com/content/v1/6a109d01192d89623b1d718f/1779473718029-0ZD9A0MWSRFSE009BAIX/Untitled+design+%2879%29.png</image:loc>
      <image:title>Management Team</image:title>
    </image:image>
    <image:image>
      <image:loc>https://images.squarespace-cdn.com/content/v1/6a109d01192d89623b1d718f/1779473718038-3VB2CPFOKTT4S68H1MFO/Untitled+design+%287%29.png</image:loc>
      <image:title>Management Team</image:title>
    </image:image>
    <image:image>
      <image:loc>https://images.squarespace-cdn.com/content/v1/6a109d01192d89623b1d718f/1779473718046-DAY98MB1TJ87GPRUZ7PY/6+%286%29.png</image:loc>
      <image:title>Management Team</image:title>
    </image:image>
    <image:image>
      <image:loc>https://images.squarespace-cdn.com/content/v1/6a109d01192d89623b1d718f/1779473718054-17MNQE188A50MWTDDKO7/7+%285%29.png</image:loc>
      <image:title>Management Team</image:title>
    </image:image>
    <image:image>
      <image:loc>https://images.squarespace-cdn.com/content/v1/6a109d01192d89623b1d718f/13112fba-6020-40bc-b6c6-b80082a2982e/Idean+Marvasty.png</image:loc>
      <image:title>Management Team</image:title>
    </image:image>
    <image:image>
      <image:loc>https://images.squarespace-cdn.com/content/v1/6a109d01192d89623b1d718f/a689e7f6-5209-45c3-b8c9-3d700657d43e/Boris-Rogovoy-upscale2.png</image:loc>
      <image:title>Management Team</image:title>
    </image:image>
    <image:image>
      <image:loc>https://images.squarespace-cdn.com/content/v1/6a109d01192d89623b1d718f/838bb5f6-5984-422c-9b76-a8df2cc56d07/Haishan+Li+2.png</image:loc>
      <image:title>Management Team</image:title>
    </image:image>
  </url>
</urlset>

